Abstract Within a double-blind, cross-above trial, triazolam (0.25 mg) was tested against flunitrazepam (1 mg) in the typical midwinter insomnia that is generally noticed amid normally healthier folks in Northern Norway. Every drug was offered for 5 evenings, in random buy, that has a 5-night placebo interval between the Lively medicine (offering f